Nuwellis (NUWE) Cash from Investing Activities Growth (3y) (2014 - 2026)
Nuwellis (NUWE) Cash from Investing Activities Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | 17.83% |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn | -6.23% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | -24.52% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | -32.54% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -68.12% |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn | 37.39% |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn | -11.04% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 19.58% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | -17.67% |
| 10 | Nuwellis | 203,898.38 | -3.72 Mn | 1.50 Mn | -26.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.36% |
| Mar 31, 2026 | -42.57% |
| Dec 31, 2025 | -90.68% |
| Sep 30, 2025 | -64.54% |
| Jun 30, 2025 | 28.62% |
| Dec 31, 2024 | 88.60% |
| Sep 30, 2024 | 31.93% |
| Jun 30, 2024 | 33.33% |
| Mar 31, 2024 | 19.70% |
| Dec 31, 2023 | 37.51% |
| Sep 30, 2023 | 4.29% |
| Jun 30, 2023 | 128.08% |
| Mar 31, 2023 | -79.30% |
| Dec 31, 2022 | 730.31% |
| Sep 30, 2022 | 58.42% |
| Jun 30, 2022 | 54.53% |
| Mar 31, 2022 | -19.52% |
| Dec 31, 2021 | -804.27% |
| Sep 30, 2021 | 1.20% |
| Jun 30, 2021 | -8.17% |